EQS-Adhoc

European Healthcare Acquisition & Growth Company B.V.: Expiry and delisting of the Warrants on 17 November 2023

EQS-Ad-hoc: European Healthcare Acquisition & Growth Company B.V. / Key word(s): Miscellaneous European Healthcare Acquisition & Growth Company B.V.: Expiry and delisting of the Warrants on 17 November 2023 10-Nov-2023 / 07:30 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. NOT FOR DISTRIBUTION, PUBLICATION OR FORWARDING, EITHER DIRECTLY OR INDIRECTLY, IN OR TO CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS PUBLICATION.

 

Public disclosure of inside information according to Article 17 para. 1 of the Regulation (EU) No 596/2014 on market abuse (Market Abuse Regulation)

 

European Healthcare Acquisition & Growth Company B.V. – Expiry and delisting of the Warrants on 17 November 2023

 

Munich, 10 November 2023

European Healthcare Acquisition & Growth Company B.V. (the "Company"), a Dutch operators-led special purpose acquisition company listed on Euronext Amsterdam, today announces that the class A warrants (the "Public Warrants") and the class B warrants (the "Founder Warrants" and together with the Public Warrants, the "Warrants") will expire worthless on the original business combination deadline, being 17 November 2023.

On 4 October 2023, the board of the Company proposed that in the context of the proposed extension of the business combination deadline as announced in the Company's press release of 20 September 2023 and as further set out in the agenda and explanatory notes of the EGM to be held on 15 November 2023, the holders of the Warrants amend the terms and conditions of the Warrants (the "Warrant T&C") to have all Warrants expire worthless on the original business combination deadline, being 17 November 2023, as the Warrants have proved to impede the Company's chances of successfully executing a business combination.